The results aren’t published yet, but it looks like we’re going to see that the anti-obesity GLP-1 drugs such as Zepbound are potentially useful for treating sleep apnea too.

I’m curious how much of that comes from the associated weight loss - there is a known relationship between e.g. sleep apnea and obesity, albeit potentially a fairly complicated one - vs if there’s a more direct pathway in addition.